NVIDIA is stepping up its efforts to fight cancer using artificial intelligence. The GPU manufacturer is partnering with Medtronic to integrate artificial intelligence into the GI Genius endoscopy instrument. The two manufacturers will use NVIDIA’s IGX hardware and Holoscan medical platform to help detect polyps that can lead to colorectal cancer. Doctors will get diagnostic images “enhanced by artificial intelligence“, say the companies.
I primi sistemi GI Genius made with NVIDIA technology should arrive later in the year. The device can use a number of artificial intelligence tools, and Medtronic is betting that using NVIDIA’s Clara platform could help develop algorithms for real-time medical procedures.
The news comes in conjunction with the expansion of the service BioNeMo Cloud from NVIDIA, which helps bring theGenerative AI in drug discovery. The new offering helps train AI models (and handle inference) used to develop new therapeutic proteins and advance other fields such as biology and chemistry. NVIDIA claims researchers can speed up one of the longest processes in their pipeline.
This comes just after Google unveiled an AI technology for cancer therapy and ultrasound diagnosis. In recent years, other tech giants have devoted more of their AI work to healthcare. Intel has partnered with Penn Medicine to detect brain tumors, while Microsoft has sought to speed up the diagnosis of cervical cancer and take some of the workload off doctors.
To continue reading other tech news, you can click Who!
